Home / Inspections / 1240497

FDA Inspection 1240497 — Manhattan Reproductive Medicine, PC

Manhattan Reproductive Medicine, PC — FEI 3004753417

The FDA completed an inspection of Manhattan Reproductive Medicine, PC on May 24, 2024 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 24, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Facility

Other inspections at this facility

  • 1173216 (NAI Wed Jun 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117589 (VAI Wed Feb 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895464 (OAI Thu Sep 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 842598 (OAI Wed Jul 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 635463 (VAI Thu Jan 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources